Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 2 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 12201683

    Methods for preventing dengue and hepatitis a

    Takeda Vaccines, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  2. US 12201685

    Methods of modulating immune responses with cationic lipid vaccine compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  3. US 12194090

    Tetanus vaccine platform for embedding COVID-19 vaccine

    Prime Bio, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  4. US 12194084

    Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

    Northwestern University · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  5. US 12187782

    PDL1 peptides for use in cancer vaccines

    IO Biotech ApS · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  6. US 12188072

    Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates

    Northwestern University · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  7. US 12186342

    Autologous irradiated whole cell tumor vaccines lentivirally engineered to express CD80, IL-15 and IL-15 receptor alpha

    The Regents of the University of California · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  8. US 12186363

    Compositions and methods for dengue virus chimeric constructions in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  9. US 12186384

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  10. US 12162950

    Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

    The Regents of the University of California · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  11. US 12161706

    Cancer vaccines targeting BORIS and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  12. US 12109260

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  13. US 12102671

    Method of vaccination with an attenuated RSV vaccine formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  14. US 12097291

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  15. US 12071636

    Pasteurella multocida strains and vaccines having hyaC and nanP deletions

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  16. US 12070495

    HIV RNA vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  17. US 12070500

    Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis

    VACCINEX, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  18. US 12064511

    Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy

    The Regents of the University of California · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  19. US 12064472

    Southern cattle tick vaccine product

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  20. US 12064473

    Cancer vaccines targeting Survivin and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  21. US 12054519

    Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  22. US 12049479

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  23. US 12036278

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics (Nevada), Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  24. US 12018052

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted